2024-04590. Clinical Laboratory Improvement Amendments of 1988 (CLIA) Fees; Histocompatibility, Personnel, and Alternative Sanctions for Certificate of Waiver Laboratories; Correction  

  • Start Preamble Start Printed Page 15755

    AGENCY:

    Centers for Medicare & Medicaid Services (CMS) and Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS).

    ACTION:

    Final rule; correction.

    SUMMARY:

    This document corrects technical and typographical errors in the final rule that appeared in the December 28, 2023, Federal Register entitled, “Clinical Laboratory Improvement Amendments of 1988 (CLIA) Fees; Histocompatibility, Personnel, and Alternative Sanctions for Certificate of Waiver Laboratories” (referred to hereafter as the “December 2023 final rule”).

    DATES:

    This correction is effective March 5, 2024, and is applicable beginning January 27, 2024.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Penny Keller, CMS, (410) 786–2035; or Heather Stang, CDC, (404) 498–2769.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    I. Background

    In FR Doc. 2023–28170 of December 28, 2023, the December 2023 final rule (88 FR 89976), there were technical and typographical errors that are identified and corrected in this correcting document. These corrections are applicable beginning January 27, 2024, as if they had been included in the December 2023 final rule.

    II. Summary of Errors

    On page 89985, in the first footnote to the table titled, “TABLE 4: Examples, Two-part Increase per Certificate Type”, we inadvertently included incorrect amounts for the current and updated Certificate of Registration (CoR) fees. As stated in the proposed rule that appeared in the July 26, 2022, Federal Register entitled, “Clinical Laboratory Improvement Amendments of 1988 (CLIA) Fees; Histocompatibility, Personnel, and Alternative Sanctions for Certificate of Waiver Laboratories”, the correct current CoR fee was $100. With application of the one-time across-the-board (ATB) increase of 18 percent along with the biennial two-part fee increase of 4.9598 percent, the correct updated fee amount is $123.

    Similarly on page 90027, in the table titled, “TABLE 17: Two-part Biennial Certificate Fee”, in the Certificate of Registration (CoR) row, we inadvertently included incorrect amounts in the “Current fee” and “New average fee” columns. We are correcting as described previously.

    On page 90028, in the table titled, “TABLE 18: CLIA Replacement and Revised Certificates FY 2019”, we made typographical errors in the “Cost of Revised Certificate” entries for the Certificate of Accreditation (CoA) and Certificate for Provider-performed Microscopy (PPM) certificate types. The amounts were reversed in the table. The corrected certificate fees for each of these revised certificate types corresponds to the fees in Table 6, “CMS Proposed Fee for Issuance of Revised Certificate” in the final rule.

    III. Waiver of Proposed Rulemaking and Delay in Effective Date

    Under 5 U.S.C. 553(b) of the Administrative Procedure Act (APA), the agency is required to publish a notice of the proposed rulemaking in the Federal Register before the provisions of a rule take effect. Section 553(d) of the APA ordinarily requires a 30-day delay in effective date of final rules after the date of their publication in the Federal Register .

    Section 553(b)(B) of the APA authorizes an agency to dispense with normal rulemaking requirements for good cause if the agency makes a finding that the notice and comment process is impracticable, unnecessary, or contrary to the public interest. In addition, section 553(d)(3) of the APA allows the agency to avoid the 30-day delay in effective date where such delay is contrary to the public interest and an agency includes a statement of support.

    We believe this correcting document does not constitute a rule that would be subject to the notice and comment or delayed effective date requirements. This document merely corrects technical and typographical errors in the December 2023 final rule but does not make substantive changes to the policies that were adopted in the December 2023 final rule. Instead, this correcting document is intended to ensure that the information in the December 2023 final rule accurately reflects the policies adopted in that document.

    In addition, even if this were a rule to which the notice and comment procedures and delayed effective date requirements applied, we find that there is good cause to waive such requirements. Undertaking further notice and comment procedures to incorporate the corrections in this document into the December 2023 final rule or delaying the effective date would be contrary to the public interest because it is in the public's interest to ensure that the December 2023 final rule accurately reflects the policies finalized in that final rule. Furthermore, such procedures would be unnecessary, as we are not altering our policies, but rather, we are simply correctly implementing the policies we finalized. This final rule correction is intended to ensure that the December 2023 final rule accurately reflects those policies. Therefore, we believe we have good cause to waive the notice and comment and delayed effective date requirements.

    IV. Correction of Errors

    In FR Doc. 2023–28170 of Thursday, December 28, 2023 (88 FR 89976), the following corrections are made:

    1. On page 89985, in the first footnote to the table titled, “TABLE 4: Examples, Two-part Increase per Certificate Type”, the language that reads, “Note: The Certificate of Registration (CoR) fee would increase from the $150 to $184.” is corrected to read, “Note: The Certificate of Registration (CoR) fee would increase from the $100 to $123.”

    2. On page 90027, in the table titled, “TABLE 17: Two-part Biennial Certificate Fee”, the last row that reads: Start Printed Page 15756

    Table 17—Two-Part Biennial Certificate Fee

    Type of CLIA CertificateLaboratory scheduleCurrent fee (c)New average (n) ATB and biennial increase = 18% * 4.96%Number of laboratories *Number of laboratories divided by 2 **
    Certificate of Registration (CoR)Not applicable$150$18428911,445.5

    is corrected to read:

    Table 17—Two-Part Biennial Certificate Fee

    Type of CLIA CertificateLaboratory scheduleCurrent fee (c)New average (n) ATB and biennial increase = 18% * 4.96%Number of laboratories *Number of laboratories divided by 2 **
    Certificate of Registration (CoR)Not applicable$100$12328911,445.5

    3. On page 90028, in the table titled, “TABLE 18: CLIA Replacement and Revised Certificates FY 2019”, rows 4 and 5 that read:

    Table 18—CLIA Replacement and Revised Certificates FY2019 *

    Certificate typeNumber of replacement certificates issued in FY2019Cost of replacement certificateNumber of revised certificates issued in FY2019Cost of revised certificate
    CoA496$75505$150
    PPM5257598495

    are corrected to read:

    Table 18—CLIA Replacement and Revised Certificates FY2019 *

    Certificate typeNumber of replacement certificates issued in FY2019Cost of replacement certificateNumber of revised certificates issued in FY2019Cost of revised certificate
    CoA496$75505$95
    PPM52575984150
    Start Signature

    Elizabeth J. Gramling,

    Executive Secretary to the Department, Department of Health and Human Services.

    End Signature End Supplemental Information

    [FR Doc. 2024–04590 Filed 3–4–24; 8:45 am]

    BILLING CODE 4120–01–P

Document Information

Effective Date:
3/5/2024
Published:
03/05/2024
Department:
Centers for Medicare & Medicaid Services
Entry Type:
Rule
Action:
Final rule; correction.
Document Number:
2024-04590
Dates:
This correction is effective March 5, 2024, and is applicable beginning January 27, 2024.
Pages:
15755-15756 (2 pages)
Docket Numbers:
CMS-3326-CN2
RINs:
0938-AT47: Clinical Laboratory Improvement Amendments of 1988 (CLIA) Fees; Histocompatibility, Personnel, and Alternative Sanctions for Certificate of Waiver Laboratories (CMS-3326)
RIN Links:
https://www.federalregister.gov/regulations/0938-AT47/clinical-laboratory-improvement-amendments-of-1988-clia-fees-histocompatibility-personnel-and-altern
PDF File:
2024-04590.pdf
CFR: (1)
42 CFR 493